On the front page of its "Business" section, the New York Times 
(12/5, B1, Thomas, Subscription Publication) reports on a study published in the journal Circulation, which found that "while aspirin may prevent heart attacks and strokes, a commonly used coating to protect the stomach may obscure the benefits, leading doctors to prescribe more expensive prescription drugs. The conclusion about coated aspirin was only one finding in the study, whose main goal was to test the hotly disputed idea that aspirin does not help prevent heart attacks or stroke in some people." Dr. Garret FitzGerald, chairman of pharmacology at the University of Pennsylvania and one of the study's authors, said in a statement, "These studies question the value of coated, low-dose aspirin. This product adds cost to treatment, without any clear benefit. Indeed, it may lead to the false diagnosis of aspirin resistance and the failure to provide patients with an effective therapy."
(12/5, B1, Thomas, Subscription Publication) reports on a study published in the journal Circulation, which found that "while aspirin may prevent heart attacks and strokes, a commonly used coating to protect the stomach may obscure the benefits, leading doctors to prescribe more expensive prescription drugs. The conclusion about coated aspirin was only one finding in the study, whose main goal was to test the hotly disputed idea that aspirin does not help prevent heart attacks or stroke in some people." Dr. Garret FitzGerald, chairman of pharmacology at the University of Pennsylvania and one of the study's authors, said in a statement, "These studies question the value of coated, low-dose aspirin. This product adds cost to treatment, without any clear benefit. Indeed, it may lead to the false diagnosis of aspirin resistance and the failure to provide patients with an effective therapy."
The Wall Street Journal (12/5, Winslow, Subscription Publication) reports that the study was funded by the National Heart, Lung and Blood Institute, the American Heart Association and Bayer. Bayer's HealthCare unit noted that the findings should not discourage use of coated aspirin because studies have shown that it cuts heart risk with a low incidence of gastrointestinal bleeding.
(12/5, Winslow, Subscription Publication) reports that the study was funded by the National Heart, Lung and Blood Institute, the American Heart Association and Bayer. Bayer's HealthCare unit noted that the findings should not discourage use of coated aspirin because studies have shown that it cuts heart risk with a low incidence of gastrointestinal bleeding.
No comments:
Post a Comment